David C. Fajgenbaum, MD, MBA, MSc

faculty photo
Research Assistant Professor of Medicine
Department: Medicine
Graduate Group Affiliations

Contact information
Hospital of the University of Pennsylvania (HUP)
Division of Medical Genetics
5th Floor Silverstein, Suite S05094
3400 Spruce Street
Philadelphia, PA 19104
Fax: 877-991-9674
Lab: 215-614-0936
BS (Human Sciences with Distinction, Magna Cum Laude)
Georgetown University, Washington, DC, 2007.
MSc (Public Health)
University of Oxford, Oxford, UK, 2008.
MD (Medicine)
University of Pennsylvania Perelman School of Medicine, 2013.
MBA (Health Care Management Program)
Wharton School of Business, University of Pennsylvania, 2015.
Permanent link

Description of Research Expertise

Dr. Fajgenbaum holds expertise related to Castleman disease and other hematologic, oncologic and inflammatory diseases. He is also an expert regarding orphan and hematology/oncology drug development, translational research, health care/social entrepreneurship, health policy/public health, bereavement, college student mental health and non-profit development.

Selected Publications

Frits van Rhee & David C. Fajgenbaum: Ask the Hematologists: What are your treatment approaches to Castleman disease with the advent of anti–interleukin-6 therapy? The Hematologist: ASH News and Reports. 12(2): 4-5, 2015.

David C. Fajgenbaum: A Rare Disease That Picked the Wrong Family: Fighting Back to Help a Loved One and as a Tool for Actively Coping. A review of Rare, a documentary video produced directed by Maren Grainger-Monsen and Nicole Newnham. 56 minutes. 2012. Palo Alto, CA: Stanford University Center for Biomedical Ethics. Death Studies. 39(10): 673-6, 2015.

Heather Servaty-Seib & David C. Fajgenbaum: We Get It: Voices of Grieving College Students and Young Adults. Jessica Kingsley Publishers. Jessica Kingsley Publishers, 2015.

David C. Fajgenbaum, Amy Liu, Jason Ruth, Chris Nabel, Brian Finkelman, Razelle Kurzrock, Frits van Rhee, Arthur Rubenstein : HHV-8-Negative, Idiopathic Multicentric Castleman Disease (iMCD): A Description of Clinical Features and Therapeutic Options through a Systematic Literature Review. Blood (ASH Annual Meeting Abstracts). 124:Abstract 4861, 2014.

David C. Fajgenbaum, Frits van Rhee, Chris Nabel: HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 123: 2924-2933, 2014.

David C. Fajgenbaum, Frits van Rhee, Adnan Nasir, Misha Rosenbach, Jason Reutter: Eruptive Cherry Hemangiomatosis associated with Multicentric Castleman’s Disease: A Case Report and possible Mechanism. JAMA Dermatology. 149(2): 204-208, 2013.

David C. Fajgenbaum & Lisa Fajgenbaum: Death and Loss in the Future as it Relates to Young Adults and National Students of AMF. The ADEC Forum. 39(2): 1, 2013.

David C. Fajgenbaum: National Students of AMF: Peer Support and Service as Therapeutic Supports Among Grieving College Students. The ADEC Forum. 38(2): 24-38, 2012.

David C. Fajgenbaum, Ben Chesson, Robin Lanzi: Building a Network of Grief Support on College Campuses: A National Grassroots Initiative. The Journal of College Student Psychotherapy. 26(2): 99-120, 2012.

back to top
Last updated: 12/04/2017
The Trustees of the University of Pennsylvania